TrialScientific reports2025

A randomized controlled trial comparing romosozumab and denosumab in elderly women with primary osteoporosis and knee osteoarthritis.

Yasumori Sobue et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.